Dual- versus single-agent HER2 inhibition and incidence of intracranial metastatic disease: a systematic review and meta-analysis

Observational studies have suggested that HER2 inhibition with trastuzumab may be associated with an increased incidence of intracranial metastatic disease (IMD) due to its ability to prolong survival. We hypothesized that prolonged survival associated with dual-agent HER2 inhibition may be associat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:NPJ Breast Cancer
Main Authors: Erickson, Anders Wilder, Habbous, Steven, Hoey, Christianne, Jerzak, Katarzyna J., Das, Sunit
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2021
Assuntos:
Review Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7892568/
https://ncbi.nlm.nih.gov/pubmed/33602948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-021-00220-0
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares